Table 2.
Laboratory Data at Baseline and Follow‐Up
| Patients With Favorable Response (n=39) | Patients With Less Favorable Response (n=45) | P Value | |
|---|---|---|---|
| LDL cholesterol (baseline), mg/dL | 78.4 (60.0 to 104.6) | 91.5 (73.1 to 116.6) | 0.063 |
| LDL cholesterol (follow‐up), mg/dL | 68.1 (53.8 to 78.6) | 76.1 (67.5 to 90.8) | 0.068 |
| LDL cholesterol change, mg/dL | −14.5 (−31.8 to 6.7) | −14.6 (−47.3 to 0.0) | 0.512 |
| P value | 0.025 | 0.001 | |
| HDL cholesterol (baseline), mg/dL | 42.1 (36.1 to 53.3) | 42.0 (38.5 to 53.2) | 0.931 |
| HDL cholesterol (follow‐up), mg/dL | 40.0 (35.9 to 46.9) | 43.1 (36.2 to 51.3) | 0.898 |
| HDL cholesterol change, mg/dL | 0.8 (−6.2 to 5.3) | −1.5 (−6.3 to 5.9) | 0.806 |
| P value | 0.538 | 0.803 | |
| Triglyceride (baseline), mg/dL | 167.0 (108.2 to 207.3) | 150.6 (98.5 to 196.9) | 0.350 |
| Triglyceride (follow‐up), mg/dL | 125.3 (95.7 to 160.6) | 128.9 (88.6 to 174.6) | 0.898 |
| Triglyceride change, mg/dL | −23.5 (−86.1 to 10.6) | 0.0 (−47.7 to 21.0) | 0.174 |
| P value | 0.007 | 0.304 | |
| hs‐CRP (baseline), mg/dL | 2.0 (1.0 to 4.0) | 1.0 (0.0 to 2.0) | 0.099 |
| hs‐CRP (follow‐up), mg/dL | 1.0 (0.5 to 1.8) | 1.0 (0.0 to 2.0) | 0.416 |
| hs‐CRP change, mg/dL | −1.0 (−2.8 to 0.0) | 0.0 (−1.0 to 0.0) | 0.221 |
| P value | 0.007 | 0.272 |
Values are median (interquartile range). Significance was calculated by Mann‐Whitney U tests and Wilcoxon signed rank tests. Sample size: 84 patients. HDL indicates high‐density lipoprotein; hs‐CRP, high‐sensitivity C‐reactive protein; and LDL, low‐density lipoprotein.